Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs SSNC✓SelectedUSD · SSNCGSK vs SSNC performance historyLatest closeAs of+0.52%11/13
Stock and ETF performance explorer

GSK vs SSNC

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+105.2%
SSNC return
+184.6%
Excess return
-79.4%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioSSNCExcessAlpha
1D+0.5%+0.2%+0.4%+0.5%
7D+1.1%+2.3%-1.2%+0.6%
30D+6.3%-3.1%+9.4%+7.0%
3M+1.8%-2.7%+4.6%+2.3%
6M+1.7%+23.7%-22.0%-3.3%
YTD+6.5%-8.0%+14.6%+7.7%
1Y+9.5%-4.7%+14.2%+9.7%
3Y+65.3%+58.0%+7.3%+45.9%
5Y+43.7%+8.0%+35.8%+36.9%
All+105.2%+184.6%-79.4%+58.6%

Cumulative growth

Daily Returns

Daily percentage return beside SSNC.

Daily Out/Under-Performance

Portfolio return minus SSNC return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × SSNC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded SSNC wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling